Revvity on Monday beat Wall Street estimates for its quarterly profit and revenue, helped by better-than-expected demand for ...

The U.S. Food and Drug Administration (FDA) on Monday tightened regulations for clinical laboratories with a new rule that ...

Diagnostic Contract Manufacturing market in terms of revenue was estimated to be worth $26.0 billion in 2023 and is poised to ...

The Food and Drug Administration (FDA) is revising long-standing rules to place laboratory tests under the same jurisdiction ...

Laboratory-developed tests can assess the risks of developing Alzheimer's disease or guide the treatment of breast cancer.

An AI-powered tool may be able to detect pancreatic, gastric, or colorectal cancer with a sensitivity of 82–100% and takes ...

The FDA approved its first gene therapy companion diagnostic test last June, developed through a collaboration between ARUP ...

No home-monitoring vision test has the diagnostic accuracy of hospital eye service follow-up clinics to identify active ...

If a patient tests positive for antibodies to AAVRh74var, Beqvez should not be administered. “The approval of the nAbCyte companion diagnostic represents a first for a gene therapy that treats ...

Labcorp (LH) announced the FDA has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic to determine patient ...

LONDON, April 29, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced a partnership with Riskonnect to pilot an innovative analytical ...

Labcorp's nAbCyte Assay has been approved by the FDA as a companion diagnostic for Pfizer's gene therapy in treating ...